GlaxoSmithKline to transfer rights to Iodex and Ostocalcium for Rs 16.5bn
GlaxoSmithKline Pharmaceuticals Limited said that it will transfer its rights pertaining to the Iodex pain relief and Ostocalcium brands to GlaxoSmithKline Asia Private Limited for ... Read More